Business Description
Medacta Group SA
ISIN : CH0468525222
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.49 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 0.33 | |||||
Interest Coverage | 12.31 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.72 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.8 | |||||
3-Year EBITDA Growth Rate | 10.4 | |||||
3-Year EPS without NRI Growth Rate | 3.8 | |||||
3-Year Book Growth Rate | 20.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 27.64 | |||||
Future 3-5Y Total Revenue Growth Rate | 12.85 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.2 | |||||
Quick Ratio | 0.84 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 438.37 | |||||
Days Sales Outstanding | 64.89 | |||||
Days Payable | 86.89 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 0.03 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.93 | |||||
Operating Margin % | 13.67 | |||||
Net Margin % | 10.36 | |||||
FCF Margin % | -2.83 | |||||
ROE % | 17.28 | |||||
ROA % | 8.1 | |||||
ROIC % | 9.94 | |||||
ROC (Joel Greenblatt) % | 15.67 | |||||
ROCE % | 13.4 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 40.36 | |||||
Forward PE Ratio | 18.58 | |||||
PE Ratio without NRI | 40.36 | |||||
PEG Ratio | 4.29 | |||||
PS Ratio | 4.17 | |||||
PB Ratio | 6.53 | |||||
Price-to-Tangible-Book | 7.64 | |||||
Price-to-Operating-Cash-Flow | 28.57 | |||||
EV-to-EBIT | 31.21 | |||||
EV-to-Forward-EBIT | 23.61 | |||||
EV-to-EBITDA | 16.99 | |||||
EV-to-Forward-EBITDA | 14.49 | |||||
EV-to-Revenue | 4.21 | |||||
EV-to-Forward-Revenue | 4.02 | |||||
EV-to-FCF | -146.86 | |||||
Price-to-Projected-FCF | 6.98 | |||||
Price-to-Peter-Lynch-Fair-Value | 5.3 | |||||
Price-to-Graham-Number | 3.7 | |||||
Earnings Yield (Greenblatt) % | 3.2 | |||||
FCF Yield % | -0.69 | |||||
Forward Rate of Return (Yacktman) % | 9.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MEDGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medacta Group SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 589.484 | ||
EPS (TTM) ($) | 3.037 | ||
Beta | -0.3 | ||
Volatility % | 0.72 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 83.91 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 83.91 - 83.91 | ||
Shares Outstanding (Mil) | 19.95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medacta Group SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medacta Group SA Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Medacta Group SA Frequently Asked Questions
What is Medacta Group SA(MEDGF)'s stock price today?
When is next earnings date of Medacta Group SA(MEDGF)?
Does Medacta Group SA(MEDGF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |